6864 Stock Overview
Anti-Microbial Savior BioteQ Co., Ltd. focuses on the research and development of pharmaceutical products in Taiwan.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Anti-Microbial Savior BioteQ Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$26.65 |
| 52 Week High | NT$38.45 |
| 52 Week Low | NT$22.50 |
| Beta | 0 |
| 1 Month Change | 2.30% |
| 3 Month Change | -8.10% |
| 1 Year Change | -21.62% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -55.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6864 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | 3.7% | -0.7% | -1.6% |
| 1Y | -21.6% | -23.7% | 25.9% |
Return vs Industry: 6864 exceeded the TW Biotechs industry which returned -23.7% over the past year.
Return vs Market: 6864 underperformed the TW Market which returned 25.9% over the past year.
Price Volatility
| 6864 volatility | |
|---|---|
| 6864 Average Weekly Movement | 7.1% |
| Biotechs Industry Average Movement | 4.8% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.6% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 6864 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6864's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | n/a | www.ams-bioteq.com |
Anti-Microbial Savior BioteQ Co., Ltd. focuses on the research and development of pharmaceutical products in Taiwan. The company was founded in 2018 and is based in Kaohsiung, Taiwan.
Anti-Microbial Savior BioteQ Co., Ltd Fundamentals Summary
| 6864 fundamental statistics | |
|---|---|
| Market cap | NT$666.25m |
| Earnings (TTM) | NT$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 6864 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6864 income statement (TTM) | |
|---|---|
| Revenue | NT$0 |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$0 |
| Other Expenses | NT$0 |
| Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 6864 perform over the long term?
See historical performance and comparison